CMS4 was characterized by suppression of claudin 2, claudin 3, claudin 7, and occludin and upregulation of claudin 5 mRNAs, not aligning with any of the three TCGA genomic groups or with CMS2 despite the similarities in the prevalence of common colon cancer mutations. Here, CLDN5 is linked to malignant colon neoplasm.